Drug Profile
Levofolinic acid - AbbVie
Alternative Names: Levoleucovorin calcium pentahydrate - AbbVieLatest Information Update: 18 May 2020
Price :
$50
*
At a glance
- Originator Allergan
- Developer AbbVie
- Class Antidotes; Antineoplastics; Formyltetrahydrofolates; Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Osteosarcoma
Most Recent Events
- 08 May 2020 Allergan has been acquired and merged into AbbVie
- 27 Oct 2016 Chemical structure information added
- 29 Sep 2016 Registered for Osteosarcoma in USA (IV)